On the President’s Drug Cost Plan, Three Important Concerns
BIOtech Now Dan Durham Part 1. Restricting access under Medicare Part D The Trump administration is out with its plan to lower […]
Category: News
Drug Importation and Its Dangerous Side Effects
BIOtech Now Andrew Segerman Writing for the National Review, Sally Pipes of the Pacific Research Institute authors a stark warning about the […]
BIO Communications Responds to Misleading Op-Ed about Medicaid Drug Costs
BIOtech Now Andrew Segerman This week, Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center authored an op-ed about the cost of prescription […]
Dr. Jeremy Levin on BIO’s Path to an Addiction-Free America
BIOtech Now Andrew Segerman This week, Dr. Jeremy Levin, Chairman and CEO of Ovid Therapeutics and Chair of BIO’s Opioid Working Group […]
ICYMI: Access to Medication-Assisted Treatment Critical in Fighting Opioid Addiction
BIOtech Now Andrew Segerman Opioid abuse and addiction in America has reached epidemic heights. The Centers for Disease Control and Prevention reports […]
60 Minutes Shines Spotlight on the Power and Promise of CRISPR
BIOtech Now Andrew Segerman On Sunday night, 60 Minutes ran a captivating segment on the promise and possibilities of CRISPR – the […]
Vaccines: Vital in fighting antimicrobial resistance
BIOtech Now BIOtechNOW Editor In recognition of BIO’s 25th Anniversary, each month we are celebrating historical milestones in biotech. This week marks […]
The Latest Good News on Prescription Drug Costs
BIOtech Now Jim Greenwood Two-hundred biotech allies from more than 40 different states visited Washington D.C. this week. These advocates met with […]
Fact Checking Misleading Claims about Drug Costs
BIOtech Now Andrew Segerman In a series of new blogs, AHIP once again paints drug manufacturers as the culprit for rising health […]
A New Framework for Evaluating – and Encouraging – Industry’s IP-Sharing Activities for Global Health
BIOtech Now Rufael Seyum The Access to Medicine Foundation and BIO Ventures for Global Health (BVGH) teamed up to publish a new […]
One Health: Biotechnology Sector Ready to Act
BIOtech Now Connor McKoy Globalization has changed our models of disease. Emerging health threats throughout the world have the potential to impact […]
ICYMI: 340B: Good Intentions, Wrong Path
BIOtech Now Andrew Segerman It’s been 25 years since Congress created the 340B Drug Discount Program – a program designed to provide […]
President’s Cancer Panel Recommends Shift Towards Value
BIOtech Now Andrew Segerman This week, the President’s Cancer Panel published a new report entitled “Promoting Value, Affordability, and Innovation in Cancer […]
ICER Comes Under Renewed Scrutiny
BIOtech Now Andrew Segerman As we enter a new and exciting era of medicine, there is an important question we need to […]
Different Perspectives for AHIP to Consider During Today’s Discussion on Drug Costs
BIOtech Now Ken Lisaius This week, America’s Health Insurance Plans, or AHIP, is hosting its annual health policy conference. Included in the […]
Preparing for the Next Public Health Emergency
BIOtech Now Andrew Segerman The weather report shows a 50 percent chance of rain tomorrow. Should you pack an umbrella just in […]
Secretary Azar Talks Opioid Strategy with NGA
BIOtech Now Andrew Segerman Recently, HHS Secretary Alex Azar joined the National Governors Association to discuss opioid addiction and abuse in America. […]
Reps. Upton and Dingell on Solving America’s Opioid Crisis
BIOtech Now Andrew Segerman Writing this morning for the Detroit Free Press, Reps. Fred Upton (R-MI) and Debbie Dingell (D-MI) reinforce the need […]
Biotech is key to Achieving International Trilateral Group’s Goals
BIOtech Now George Goodno This week in Geneva three key UN agencies are meeting to address and advance their shared mission of […]
Innovation (at Home and in the Lab) Can Reduce Your Heart-Attack Risk
BIOtech Now Jim Greenwood Over the last decade, I’ve become increasingly conscious of maintaining my cardiovascular health, making dietary changes and keeping […]